No AdComm Puts Sarepta On Path To Blockbuster Success With Duchenne Gene Therapy
Noises From US FDA Positive Ahead Of PDUFA
Sarepta looks to be on the cusp of an historic approval for its Duchenne gene therapy, expected on 29 May. • Source: Shutterstock 
